2025 Regular Session • Texas Legislature
HB3265
Legislative Summary
Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor and certain prescription drug manufacturers, distributors, and related persons with respect to certain entities participating in a federal drug discount program; providing a civil penalty.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/25/2025
Filed
House of Representatives
3/20/2025
Read first time
House of Representatives
3/20/2025
Referred to Insurance
House of Representatives
4/9/2025
Scheduled for public hearing on . . .
House of Representatives
4/9/2025
Considered in public hearing
House of Representatives
4/9/2025
Testimony taken/registration(s) recorded in committee
House of Representatives
4/9/2025
Left pending in committee
House of Representatives
4/24/2025
Considered in formal meeting
House of Representatives
4/24/2025
Committee substitute considered in committee
House of Representatives
4/24/2025
Reported favorably as substituted
House of Representatives
Status Information
Current Status
Introduced(2/25/2025)
Chamber
House of Representatives
Committee
Insurance(House of Representatives)
Sponsors
Republican: 7
Democrat: 7
Primary Sponsor
Drew Darby
Republican